MDS

CURE’s myelodysplastic syndrome (MDS) page is an extensive resource of cancer information featuring the latest myelodysplastic syndrome news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on MDS.

Latest News

Reblozyl is a ‘Better First-Line Therapy’ for Anemia in MDS Subset
Reblozyl is a ‘Better First-Line Therapy’ for Anemia in MDS Subset

September 19th 2023

Reblozyl for anemia in patients with an MDS subset demonstrated positive effects, compared with previous treatments, according to an MDS expert.

Stem cells operation. Health care concept. Surgeons team working. Bone marrow transplant operation. Plasma in syringe. Selective focus. Medical room background. | Image credit: © Vadim - © stock.adobe.com
Hematopoietic Cell Transplantation ‘Potentially Curative’ for High-Risk Patients with MDS

September 17th 2023

‘General Hospital’ Star Reveals Cancer Diagnosis, Paul Reubens’ Cause of Death Confirmed and More
‘General Hospital’ Star Reveals Cancer Diagnosis, Paul Reubens’ Cause of Death Confirmed and More

September 15th 2023

Blood Cancer Approvals from Summer 2023
Blood Cancer Approvals from Summer 2023

September 2nd 2023

FDA approved
FDA Approves Reblozyl to Treat Anemia in MDS Subset

August 29th 2023